0001209191-15-068183.txt : 20150827 0001209191-15-068183.hdr.sgml : 20150827 20150827154612 ACCESSION NUMBER: 0001209191-15-068183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150826 FILED AS OF DATE: 20150827 DATE AS OF CHANGE: 20150827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151078734 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-26 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-08-26 4 M 0 10400 35.64 A 355684 D Common Stock 2015-08-26 4 S 0 900 122.09 D 354784 D Common Stock 2015-08-26 4 S 0 4082 123.09 D 350702 D Common Stock 2015-08-26 4 S 0 600 124.44 D 350102 D Common Stock 2015-08-26 4 S 0 2000 125.15 D 348102 D Common Stock 2015-08-26 4 S 0 1200 126.21 D 346902 D Common Stock 2015-08-26 4 S 0 200 126.95 D 346702 D Common Stock 2015-08-26 4 S 0 900 128.67 D 345802 D Common Stock 2015-08-26 4 S 0 518 129.51 D 345284 D Common Stock 13286 I 401(k) Common Stock 122700 I Common Stock held in trust Stock Option (right to buy) 35.64 2015-08-26 4 M 0 10400 0.00 D 2016-02-01 Common Stock 10400 229600 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $122.09 (range $121.81 to $122.71). Open market sales reported on this line occurred at a weighted average price of $123.09 (range $122.82 to $123.71). Open market sales reported on this line occurred at a weighted average price of $124.44 (range $123.84 to $124.75). Open market sales reported on this line occurred at a weighted average price of $125.15 (range $124.88 to $125.76). Open market sales reported on this line occurred at a weighted average price of $126.21 (range $125.88 to $126.66). Open market sales reported on this line occurred at a weighted average price of $126.95 (range $126.95 to $126.95). Open market sales reported on this line occurred at a weighted average price of $128.67 (range $128.03 to $128.93). Open market sales reported on this line occurred at a weighted average price of $129.51 (range $129.25 to $129.85). Fully vested. Omar White, Attorney-In-Fact 2015-08-27